{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T14:27:49Z","timestamp":1788791269976,"version":"build-2803163510"},"reference-count":15,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.htct.2026.106436","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:35:40Z","timestamp":1785414940000},"page":"106436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Improving engraftment in autologous hematopoietic stem cell transplantation: comparing pegfilgrastim with filgrastim in an outpatient setting"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9876-3633","authenticated-orcid":false,"given":"Cesar Homero","family":"Gutierrez-Aguirre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0080-487X","authenticated-orcid":false,"given":"Fernando De","family":"la Garza-Salazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0460-6427","authenticated-orcid":false,"given":"David","family":"G\u00f3mez-Almaguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6804-9095","authenticated-orcid":false,"given":"Jos\u00e9 Carlos","family":"Jaime-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4292-8635","authenticated-orcid":false,"given":"Mar\u00eda del Consuelo","family":"Mancias-Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6904-9345","authenticated-orcid":false,"given":"Andr\u00e9s G\u00f3mez-de","family":"Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9937-439X","authenticated-orcid":false,"given":"Perla","family":"Colunga-Pedraza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana Jazm\u00edn Moedano","family":"Mata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica del Carmen Estrada","family":"Rosales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2134-3734","authenticated-orcid":false,"given":"Olga Graciela","family":"Cat\u00fa-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.htct.2026.106436_bib0001","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41408-019-0205-9","article-title":"Current status of autologous stem cell transplantation for multiple myeloma","volume":"9","author":"Hamed","year":"2019","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.htct.2026.106436_bib0002","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.clml.2017.05.018","article-title":"Autologous stem cell transplantation in patients with multiple myeloma: an activity-based costing analysis, comparing a total inpatient model versus an early discharge model","volume":"17","author":"Martino","year":"2017","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.htct.2026.106436_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/20406207221080739","article-title":"Outpatient allogeneic hematopoietic stem cell transplantation: a review","volume":"13","author":"G\u00f3mez-Almaguer","year":"2022","journal-title":"Ther Adv Hematol"},{"issue":"28","key":"10.1016\/j.htct.2026.106436_bib0004","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1200\/JCO.2015.62.3488","article-title":"Recommendations for the use of WBC growth factors: american society of clinical oncology clinical practice guideline update","volume":"33","author":"Smith","year":"2015","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.htct.2026.106436_bib0005","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1080\/16078454.2022.2059630","article-title":"High-dose melphalan is an adequate preparative regimen for autologous hematopoietic stem cell transplantation in relapsed\/refractory lymphoma","volume":"27","author":"Guti\u00e9rrez-Fern\u00e1ndez","year":"2022","journal-title":"Hematology"},{"key":"10.1016\/j.htct.2026.106436_bib0006","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1007\/s12325-018-0798-6","article-title":"Systematic review and meta-analysis of short versus long-acting granulocyte colony-stimulating factors for reduction of chemotherapy-induced febrile neutropenia","volume":"35","author":"Cornes","year":"2018","journal-title":"Adv Ther"},{"key":"10.1016\/j.htct.2026.106436_bib0007","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3111\/13696998.2013.782034","article-title":"A retrospective study of the clinical and economic burden during hospitalizations among cancer patients with febrile neutropenia","volume":"16","author":"Dulisse","year":"2013","journal-title":"J Med Econ"},{"key":"10.1016\/j.htct.2026.106436_bib0008","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1399-0012.2011.01532.x","article-title":"Pegfilgrastim versus filgrastim for supportive care after autologous stem cell transplantation: can we decide?","volume":"26","author":"Ziakas","year":"2012","journal-title":"Clin Transplant"},{"issue":"1","key":"10.1016\/j.htct.2026.106436_bib0009","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/1078155220974085","article-title":"A retrospective review of the real-world experience of the pegfilgrastim biosimilar (Lapelga\u00ae) to the reference biologic (Neulasta\u00ae)","volume":"28","author":"Wong","year":"2022","journal-title":"J Oncol Pharm Practice"},{"key":"10.1016\/j.htct.2026.106436_bib0010","article-title":"Comparison of fixed dose pegfilgrastim and daily filgrastim after autologous stem cell transplantation in patients with multiple myeloma autografted on a outpatient basis","author":"Ferrara","year":"2010","journal-title":"Hematol Oncol"},{"issue":"Suppl 5","key":"10.1016\/j.htct.2026.106436_bib0011","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/annonc\/mdw325","article-title":"On behalf of the ESMO guidelines committee. management of febrile neutropaenia: ESMO clinical practice guidelines","volume":"27","author":"Klastersky","year":"2016","journal-title":"Annal Oncology"},{"key":"10.1016\/j.htct.2026.106436_bib0012","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1177\/1078155215625459","article-title":"Comparative effectiveness of granulocyte colony-stimulating factors to prevent febrile neutropenia and related complications in cancer patients in clinical practice: a systematic review","volume":"22","author":"Mitchell","year":"2016","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.htct.2026.106436_bib0013","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1600-0609.2006.00736.x","article-title":"Pegfilgrastim compared with filgrastim after high-dose melphalan and autologous hematopoietic peripheral blood stem cell transplantation in multiple myeloma patients","volume":"77","author":"Martino","year":"2006","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.htct.2026.106436_bib0014","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1038\/bmt.2009.373","article-title":"Retrospective comparison of the effects of filgrastim and pegfilgrastim on the pace of engraftment in auto-SCT patients","volume":"45","author":"Mathew","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.htct.2026.106436_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2020.12.006","article-title":"Outpatient haploidentical stem cell transplantation using post-transplant cyclophosphamide is safe and feasible","volume":"27","author":"Colunga-Pedraza","year":"2021","journal-title":"Transplant Cell Ther"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137926001835?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137926001835?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:29:51Z","timestamp":1788787791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137926001835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2531137926001835"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2026.106436","relation":{},"ISSN":["2531-1379"],"issn-type":[{"value":"2531-1379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improving engraftment in autologous hematopoietic stem cell transplantation: comparing pegfilgrastim with filgrastim in an outpatient setting","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2026.106436","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular.","name":"copyright","label":"Copyright"}],"article-number":"106436"}}